PT - JOURNAL ARTICLE AU - Drouard, Gabin AU - Wang, Zhiyang AU - Heikkinen, Aino AU - Foraster, Maria AU - Julvez, Jordi AU - Kanninen, Katja M. AU - van Kamp, Irene AU - Pirinen, Matti AU - Ollikainen, Miina AU - Kaprio, Jaakko TI - Lifestyle differences between co-twins are associated with decreased similarity in their internal and external exposome profiles AID - 10.1101/2023.12.12.23299868 DP - 2023 Jan 01 TA - medRxiv PG - 2023.12.12.23299868 4099 - http://medrxiv.org/content/early/2023/12/14/2023.12.12.23299868.short 4100 - http://medrxiv.org/content/early/2023/12/14/2023.12.12.23299868.full AB - Whether differences in lifestyle between co-twins are reflected in differences in their internal or external exposome profiles remains largely underexplored. We therefore investigated whether within-pair differences in lifestyle were associated with within-pair differences in exposome profiles across four domains: the external exposome, proteome, metabolome and epigenetic age acceleration (EAA). For each domain, we assessed the similarity of co-twin profiles using Gaussian similarities in up to 257 young adult same-sex twin pairs (54% monozygotic). We additionally tested whether similarity in one domain translated into greater similarity in another. Results suggest that a lower degree of similarity in co-twins’ exposome profiles was associated with greater differences in their behavior and substance use. The strongest association was identified between excessive drinking behavior and the external exposome. Overall, our study demonstrates how social behavior and especially substance use are connected to the internal and external exposomes, while controlling for familial confounders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPhenotype and omics data collection in FinnTwin12 cohort has been supported by the Wellcome Trust Sanger Institute, the Broad Institute, ENGAGE - European Network for Genetic and Genomic Epidemiology, FP7-HEALTH-F4-2007, grant agreement number 201413, National Institute of Alcohol Abuse and Alcoholism (grants AA-12502, AA-00145, and AA-09203 to R J Rose and AA15416 and K02AA018755 to D M Dick, and R01AA015416 to J Salvatore), the Academy of Finland (grants 100499, 205585, 118555, 141054, 264146, 308248 to JK, and grants 328685, 307339, 297908 and 251316 to MO, and the Centre of Excellence in Complex Disease Genetics grants 312073, 336823, and 352792 to JK), and Sigrid Juselius Foundation (to MO). This research was partly funded by the European Union's Horizon 2020 research and innovation program under grant agreement No 874724 (Equal-Life). Equal-Life is part of the European Human Exposome Network.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of the Department of Public Health of the University of Helsinki and the Institutional Review Board of Indiana University approved the FinnTwin12 study protocol from the start of the cohort. The ethical approval of the ethics committee of the Helsinki University Central Hospital District (HUS) is the most recent and covers the most recent data collection (wave 4) (HUS/2226/2021). The HUS reviews the study annually, and 2023's statement is number 4/2023, dated 1 February 2023. All participants and their parents/legal guardians gave informed written consent to participate in the study. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes